Skip to content

To see if doing more brain stimulation sessions per day over a shorter time works as well as the usual one session per day over many weeks.

A randomized clinical trial Comparing Accelerated dTMS and Standard dTMS efficacy and safety in the Treatment Resistant Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111556
Enrollment
20
Registered
2026-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F331- Major depressive disorder, recurrent, moderate

Interventions

Intervention1: Dtms(deep transcranial magnetic stimulation): Standard DTMS group will receive 20 sessions of dTMS one session/day. Each session lasting 20 minutes Control Intervention1: DTMS(Deep tran

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed with MDD according to ICD 11 criteria, which has shown poor or no response to pharmacological treatment. 2. Moderate to severe depression HDRS more than or equal to 17. 3. Patients willing to give consent for study. 4. Age 18-65 years of either gender. 5. Registered at AIIMS Psychiatry OPD 6. Patient may be on stable doses of psychotropic medication for at least 4 weeks prior to treatment

Exclusion criteria

Exclusion criteria: 1. Patients not willing to participate in study. 2. Significant comorbid severe mental illness. 3. Patients with known seizure disorder or any history of seizure. 4. History suggestive of space occupying brain lesion or cerebrovascular accident. 5. Having implanted device or cardiac pacemakers. 6. Patients having significant comorbid medical illness. 7. History of neuromodulation in past 6 months. 8. Patients with imminent suicidal risk.

Design outcomes

Primary

MeasureTime frame
To compare the change in depression, score using HAM-D and MADRS between standard DTMS and accelerated DTMS groups.Timepoint: At baseline and 3 weeks( post dTMS sessions)

Secondary

MeasureTime frame
To assess improvement in anxiety symptoms and quality of lifeTimepoint: At baseline and 3 weeks( post dTMS sessions)

Countries

India

Contacts

Public ContactGagan Hans

AIIMS New Delhi

gaganhans23@gmail.com8587090969

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026